79 related articles for article (PubMed ID: 9625429)
1. Gemcitabine--a safety review.
Aapro MS; Martin C; Hatty S
Anticancer Drugs; 1998 Mar; 9(3):191-201. PubMed ID: 9625429
[TBL] [Abstract][Full Text] [Related]
2. The double life of a chemotherapy drug: Immunomodulatory functions of gemcitabine in cancer.
Larson AC; Doty KR; Solheim JC
Cancer Med; 2024 May; 13(10):e7287. PubMed ID: 38770637
[TBL] [Abstract][Full Text] [Related]
3. Near-infrared Absorption and Emission Probes with Optimal Connection Bridges for Live Monitoring of NAD(P)H Dynamics in Living Systems.
Dwivedi SK; Arachchige DL; Waters M; Jaeger S; Mahmoud M; Olowolagba AM; Tucker DR; Geborkoff MR; Werner T; Luck RL; Godugu B; Liu H
Sens Actuators B Chem; 2024 Mar; 402():. PubMed ID: 38559378
[TBL] [Abstract][Full Text] [Related]
4. Severe and fatal interstitial lung disease induced by gemcitabine in advanced pancreatic adenocarcinoma: a case report.
Haag EK; Adjadé G; Dawood H; El Fadli M; Essadi I; Belbaraka R
Oxf Med Case Reports; 2023 Nov; 2023(11):omad120. PubMed ID: 38264204
[TBL] [Abstract][Full Text] [Related]
5. Gemcitabine-induced peripheral vascular disease and prolonged response in a patient with metastatic pancreatic adenocarcinoma: A case report.
Fabien MB; Elodie P; Anna S; Addeo P; Meher B
World J Clin Cases; 2023 Feb; 11(6):1372-1378. PubMed ID: 36926125
[TBL] [Abstract][Full Text] [Related]
6. Gemcitabine-induced digital ischaemia in a patient with metastatic breast cancer.
Khan AM; Arjyal L; Shamaileh L; Simon M
BMJ Case Rep; 2022 Nov; 15(11):. PubMed ID: 36319039
[TBL] [Abstract][Full Text] [Related]
7. Clinical Characteristics and Risk Factors of Lung Injury Induced by Nab-Paclitaxel.
Yoshioka K; Abe M; Shiko Y; Koshikawa K; Kawasaki Y; Iwasawa S; Terada J; Tsushima K; Tatsumi K; Suzuki T
Drug Des Devel Ther; 2022; 16():759-767. PubMed ID: 35345618
[TBL] [Abstract][Full Text] [Related]
8. Drug-Eluting Stents: Their Preventative/Prophylactic Role Against Gemcitabine Induced Acute Coronary Syndrome.
Hamdan JA; Youssef KN; Khan A; Abdalla MA; Zakhary CM; Rushdi H; Khan S
Cureus; 2021 Jul; 13(7):e16384. PubMed ID: 34408938
[TBL] [Abstract][Full Text] [Related]
9. Reversible renal-limited thrombotic microangiopathy due to gemcitabine-dexamethasone-cisplatin therapy: a case report.
Nishikubo M; Shimomura Y; Hiramoto N; Sawamura N; Yamaguchi T; Hara S; Ishikawa T
BMC Nephrol; 2021 May; 22(1):175. PubMed ID: 33980166
[TBL] [Abstract][Full Text] [Related]
10. Advances in Our Understanding of the Molecular Mechanisms of Action of Cisplatin in Cancer Therapy.
Tchounwou PB; Dasari S; Noubissi FK; Ray P; Kumar S
J Exp Pharmacol; 2021; 13():303-328. PubMed ID: 33776489
[TBL] [Abstract][Full Text] [Related]
11. Cardiotoxicity Associated with Gemcitabine: Literature Review and a Pharmacovigilance Study.
Hilmi M; Ederhy S; Waintraub X; Funck-Brentano C; Cohen A; Vozy A; Lebrun-Vignes B; Moslehi J; Nguyen LS; Salem JE
Pharmaceuticals (Basel); 2020 Oct; 13(10):. PubMed ID: 33096756
[TBL] [Abstract][Full Text] [Related]
12. Gemcitabine-induced pseudocellulitis: a case report and review of the literature.
Bami H; Goodman C; Boldt G; Vincent M
Curr Oncol; 2019 Oct; 26(5):e703-e706. PubMed ID: 31708665
[TBL] [Abstract][Full Text] [Related]
13. Meta‑analysis of current chemotherapy regimens in advanced pancreatic cancer to prolong survival and reduce treatment‑associated toxicities.
Chen J; Chen L; Yu J; Xu Y; Wang X; Zeng Z; Liu N; Xu F; Yang S
Mol Med Rep; 2019 Jan; 19(1):477-489. PubMed ID: 30431091
[TBL] [Abstract][Full Text] [Related]
14. Gemcitabine-Induced Cardiotoxicity in Patients Receiving Adjuvant Chemotherapy for Pancreatic Cancer: A Case Series.
Alam S; Illo C; Ma YT; Punia P
Case Rep Oncol; 2018; 11(1):221-227. PubMed ID: 29805372
[TBL] [Abstract][Full Text] [Related]
15. Gemcitabine-based chemotherapy as a viable option for treatment of advanced breast cancer patients: a meta-analysis and literature review.
Xie Z; Zhang Y; Jin C; Fu D
Oncotarget; 2018 Jan; 9(6):7148-7161. PubMed ID: 29467957
[TBL] [Abstract][Full Text] [Related]
16. Severe acute toxicity following gemcitabine administration: A report of four cases with cytidine deaminase polymorphisms evaluation.
Hryciuk B; Szymanowski B; Romanowska A; Salt E; Wasąg B; Grala B; Jassem J; Duchnowska R
Oncol Lett; 2018 Feb; 15(2):1912-1916. PubMed ID: 29434889
[TBL] [Abstract][Full Text] [Related]
17. Co-treatment with a C1B5 peptide of protein kinase Cγ and a low dose of gemcitabine strongly attenuated pancreatic cancer growth in mice through T cell activation.
Ishiguro S; Kawabata A; Zulbaran-Rojas A; Monson K; Uppalapati D; Ohta N; Inui M; Pappas CG; Tzakos AG; Tamura M
Biochem Biophys Res Commun; 2018 Jan; 495(1):962-968. PubMed ID: 29155177
[TBL] [Abstract][Full Text] [Related]
18. Nimbolide reduces CD44 positive cell population and induces mitochondrial apoptosis in pancreatic cancer cells.
Kumar S; Inigo JR; Kumar R; Chaudhary AK; O'Malley J; Balachandar S; Wang J; Attwood K; Yadav N; Hochwald S; Wang X; Chandra D
Cancer Lett; 2018 Jan; 413():82-93. PubMed ID: 29107110
[TBL] [Abstract][Full Text] [Related]
19. Cancer and liver cirrhosis: implications on prognosis and management.
Pinter M; Trauner M; Peck-Radosavljevic M; Sieghart W
ESMO Open; 2016; 1(2):e000042. PubMed ID: 27843598
[TBL] [Abstract][Full Text] [Related]
20. Acute, Unilateral Breast Toxicity From Gemcitabine in the Setting of Thoracic Inlet Obstruction.
Weiskopf K; Creighton D; Lew T; Caswell JL; Ouyang D; Shah AT; Hofmann LV; Neal JW; Telli ML
J Oncol Pract; 2016 Aug; 12(8):763-4. PubMed ID: 27511721
[No Abstract] [Full Text] [Related]
[Next] [New Search]
